Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / equity
-
Shares outstanding
-
106M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
66.8M
-
Shares change
-
+37.5K
-
Total reported value, excl. options
-
$280M
-
Value change
-
-$846K
-
Put/Call ratio
-
0.88
-
Number of buys
-
53
-
Number of sells
-
-55
-
Price
-
$4.19
Significant Holders of MAXCYTE, INC. - equity (MXCT) as of Q1 2024
132 filings reported holding MXCT - MAXCYTE, INC. - equity as of Q1 2024.
MAXCYTE, INC. - equity (MXCT) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.8M shares
of 106M outstanding shares and own 63.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.23M shares), CADIAN CAPITAL MANAGEMENT, LP (6.56M shares), MILLENNIUM MANAGEMENT LLC (6.17M shares), VANGUARD GROUP INC (5.35M shares), Vitruvian Partners LLP (5.04M shares), MORGAN STANLEY (3.52M shares), FMR LLC (3.45M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.53M shares), Mudita Advisors LLP (2.28M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.13M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.